What is Strand Therapeutics worth?
$571.0Mlast known valuation
Strand Therapeutics last raised $153.0M in its Later Stage VC (Series B) (Aug 2025).
Free account
See the evidence behind this price
- ·Post-money valuations for all 3 rounds
- ·The complete investor list — 30 names
- ·Watchlist + deal alerts for Strand Therapeutics
Create free account
No card required
Funding history
3 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Aug 2025 | Later Stage VC (Series B) | $153.0M | ▮ | ▮ |
| May 2021 | Later Stage VC | $52.1M | ▮ | ▮ |
| May 2019 | Early Stage VC | $5.9M | ▮ | ▮ |
How Strand Therapeutics's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Strand Therapeutics, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is Strand Therapeutics worth?
- Strand Therapeutics's last known valuation is $571.0M.
- How much has Strand Therapeutics raised?
- Strand Therapeutics has raised $255.6M in total funding across 3 recorded rounds.
- When did Strand Therapeutics last raise?
- Strand Therapeutics last raised in Aug 2025 (Later Stage VC (Series B)), raising $153.0M.